UCB S.A.
OTC: UCBJF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jean-Christophe Tellier
- Employees
- 9,052
- Headquarters
- Brussels, Belgium
- IPO year
- 2008
- Market cap
- $56.1B
- Website
- https://www.ucb.com
Loading UCBJF…
Loading profile data…Frequently asked questions about UCBJF
What does UCB S.A. (UCBJF) do?
UCB S.A. is a prominent biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for individuals affected by neurological and immunological disorders. Its extensive portfolio of marketed products includes Cimzia, indicated for various inflammatory TNF-mediated diseases such as Crohn's disea...
Where does UCBJF trade?
UCB S.A. (UCBJF) trades on the Other OTC.
What sector is UCBJF in?
UCB S.A. (UCBJF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of UCB S.A.?
Jean-Christophe Tellier is the chief executive officer of UCB S.A. (UCBJF).
Where is UCB S.A. headquartered?
UCB S.A. is headquartered in Belgium.
Does UCBJF pay a dividend?
Yes — UCB S.A. (UCBJF) paid a trailing twelve-month dividend of USD 1.70 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did UCBJF go public?
UCB S.A. (UCBJF) completed its initial public offering in 2008.